Cargando…
Adverse drug reaction monitoring with angiotensin converting enzyme inhibitors: A prospective, randomized, open-label, comparative study
OBJECTIVES: Angiotensin converting enzyme inhibitors (ACEIs) are known to possess different chemical structures, and change in structure of a drug can bring about change in its adverse drug reaction (ADR) profile. The study aims to observe the incidence and severity of ADRs between the di-carboxyl g...
Autores principales: | Sangole, Nishant V., Dadkar, Vaishali N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885636/ https://www.ncbi.nlm.nih.gov/pubmed/20606833 http://dx.doi.org/10.4103/0253-7613.62408 |
Ejemplares similares
-
Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors
por: Bots, Sophie H., et al.
Publicado: (2022) -
Pattern of Angiotensin-Converting Enzyme Inhibitors Induced Adverse Drug Reactions in South Indian Teaching Hospital
por: Mateti, Uday Venkat, et al.
Publicado: (2012) -
Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2015) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)